Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea (Yakult)
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A therapeutic as well as preventive role of probiotics has been suggested from results of different studies using different probiotics that have been tested, usually lactic acid producing bacteria such as lactobacillus, bifidobacterium and streptococcus species. The supplementation of probiotics to infants may also have a prophylactic effect against acute diarrhoeal diseases.
In the present proposal, we plan to examine if daily intake of a probiotic beverage, which includes 15 billion probiotic Lactobacilli, has a beneficial role in protecting children from infectious diarrhea in Kolkata.
OBJECTIVES
Primary objectives:
- To assess the impact of probiotics in the prevention of acute diarrhoeal diseases in children
- To assess the impact of probiotics on nutrition and growth of the children
Secondary Objectives:
- Reduction in duration, frequency of diarrhoea
- Identification of pathogens causing diarrhoea
- Examination of faecal microflora
STUDY DESIGN
It will be a double blind randomized controlled field trial involving 4000 children aged between 1 and 5 years in an urban slum of Kolkata, India. The 4000 children will be identified through demographic survey. The study will be double blinded where the study arm will receive Probiotic drink, which includes 15 billion probiotic Lactobacilli, one bottle (65ml) daily (under supervision of a Health Worker) for 12 weeks and the control arm will receive a similar drink without the lactobacilli (Nutrient drink) daily for 12 weeks. Randomization will be done in a ratio of 1:1, i.e., the study arm and control arm will include 2000 children each. All the children under the study will be visited daily by a health worker who will supervise intake of Probiotic drink or Nutrient drink by the children. All the children will be followed up daily for 24weeks for identification of acute diarrhoea cases.
| Condition | Intervention | Phase |
|---|---|---|
|
Diarrhea |
Dietary Supplement: Probiotic (Yakult) |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Prevention |
| Official Title: | Randomized Controlled Field Trial of a Probiotics to Assess Its Role in The Prevention of Acute Diarrhoeal Diseases in Children |
- Diarrhoeal episodes in children [ Time Frame: 10 months ]
- nutritional status in children [ Time Frame: 10 months ]
| Enrollment: | 4000 |
| Study Start Date: | June 2007 |
| Estimated Study Completion Date: | January 2008 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: A,F,T,K
Two arms are for intervention and two are for control or placebo
|
Dietary Supplement: Probiotic (Yakult)
It is a dietary supplement ,65 ml containing 15 billion lactobacillus
Other Name: Yakult
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 12 Months to 59 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Children of either sex aged 1-5 years will be eligible for screening and parents will give and a written, informed consent form will be required from either of the parents/ guardians of each participating child.
- Participating children should be free from any chronic illness and also any recent illness that may compromise the immune system. In general they will have good health without known underlying illness
Exclusion Criteria:
- Children below -2SD of the National Center for Health Statistics (NCHS) reference median in the nutritional parameters will not be enrolled.
- Children with history of diarrhoea in the preceding 2 weeks will not be eligible.
Contacts and Locations| India | |
| National Institute of Cholera and Enteric Disease | |
| Kolkata, West Bengal, India, 7000010 | |
| Principal Investigator: | Dr.Dipika Sur, MD | National Institute of Cholera and Enteric Diseases, India |
More Information
No publications provided by Indian Council of Medical Research
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00534170 History of Changes |
| Other Study ID Numbers: | YH-001 NICED 010 |
| Study First Received: | September 21, 2007 |
| Last Updated: | September 21, 2007 |
| Health Authority: | India: Indian Council of Medical Research |
Keywords provided by Indian Council of Medical Research:
|
Probiotic Prevention of diarrhoea Nutritional status |
Additional relevant MeSH terms:
|
Diarrhea Signs and Symptoms, Digestive Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013